Query Workspace - FluxAI Healthcare Demo

Query Workspace

DEfRAG Active D3R Ready

Active Trial

FLUX-ONCO-2023 | Phase II Oncology Study | 238 Documents

Conversational AI Query

Ask questions in natural language about trial documentation

Welcome to the Query Workspace. I've analyzed all 238 documents in the FLUX-ONCO-2023 trial. What would you like to know about the trial documentation?

What are the inclusion criteria for patients with prior immunotherapy?

Searching documentation...

Based on the protocol documentation (version 3.2), patients with prior immunotherapy must meet the following inclusion criteria:

  • Must have progressed after at least 2 cycles of PD-1/PD-L1 inhibitor therapy
  • Must have documented progressive disease ≥ 4 weeks after last dose
  • All immune-related adverse events must have resolved to Grade ≤ 1
  • No systemic corticosteroid use within 14 days of enrollment
Source: Protocol v3.2 (Section 4.1.2) | Amendment #2 (Page 7)

AI-Suggested Queries

Saved Queries